Entheon Biomedical Announces Enrollment in Phase 1 Study of DMT

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. JPM
2. WFC
3. ERAS
4. IBM
5. BAC
6. SPY
7. TREX
8. SPRO
9. ORCL
10. AAPL

Go back to Entheon Biomedical Announces Enrollment in Phase 1 Study of DMT
(AMEX: ENTBF) Delayed: 0.04 --0 (-0%)
Previous Close $0.04    52 Week High $ 
Open $0.04    52 Week Low $ 
Day High $0.04    P/E N/A 
Day Low $0.04    EPS $ 
Volume 11,157